Group One Trading’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Other funds holding EIGR
SAM
6CM
UOC
RC
GCP
Group One Trading's EIGR Position: Q1 2023 in Review
Group One Trading sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2023, closing a stake of 409 shares — an estimated $19K sold.
Group One Trading first reported a position in EIGR in Q2 2015 and held it in 13 quarters. The position peaked at $72K in Q1 2022. 71 funds tracked by Wall St. Rank hold EIGR as of Q1 2023.
- Group One Trading reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 409 Eiger BioPharmaceuticals, Inc. shares in Q1 2023, an estimated $19K.
- Group One Trading first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2015 and held it in 13 quarters.
- Group One Trading's Eiger BioPharmaceuticals, Inc. position peaked at $72K in Q1 2022.
- 71 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.